Precision Medicine in Acute Myeloid Leukemia Treatment

EP. 1: Genetic Alterations in Acute Myeloid Leukemia

July 22nd 2019

EP. 2: Best Practices for NGS Testing in AML

July 22nd 2019

EP. 3: Therapeutic Approaches Based on Mutations in AML

July 22nd 2019

EP. 4: Prognostic Significance of MRD in AML

July 22nd 2019

EP. 5: MRD Assessment and its Clinical Implications in AML

July 22nd 2019

EP. 6: Treatment Strategies and Patient Specific Factors in AML

July 22nd 2019

EP. 7: Consolidation Strategies in AML

July 22nd 2019

EP. 8: Role of Maintenance Therapy in AML

July 22nd 2019

EP. 9: Treatment of AML With Myelodysplasia-Related Changes

July 22nd 2019

EP. 10: Role of Hypomethylating Agents in AML

July 22nd 2019

EP. 11: Management of Adverse Events in Older Patients With AML

July 22nd 2019

EP. 12: Recent Data on the Treatment of Older Patients With AML

July 22nd 2019

EP. 13: Targeting FLT3 in Patients with Relapsed/Refractory AML

July 22nd 2019

EP. 14: Data Supporting Quizartinib in FLT3+ R/R AML

July 22nd 2019

EP. 15: Relapsed vs. Refractory Data for FLT3 Inhibitors in AML

July 22nd 2019

EP. 16: Targeting IDH1/2 in AML

July 22nd 2019

EP. 17: The Future Treatment Landscape of AML

July 22nd 2019